PO-0927: 3D-CRT whole breast irradiation: flat couch versus angulated breast board position  by Roos, J. et al.
2nd ESTRO Forum 2013   S355 
Materials and Methods: Displacement analysis was performed in 16 
trial cases with the use of the head region of a Rando Phantom; 
thermoplastic casts from Orfit (n=8) and CIVCO (n=8) cases were 
compared. The model of casts used were Hybrid masks for head (Part 
no.: 33740/NH) from Orfit and IMRT reinforced thermoplastics Head 
only (Part no.: MT-APUIR-20-32) from CIVCO. A set of three 
radiopaque markers were placed on the surface of the phantom at the 
isocentre level before making the casts, i.e. under the casts. An 
anterior marker was placed on the midline and two lateral markers 
were placed at the approximate level of anterior tragal notches. Each 
cast was then made according to the guideline from corresponding 
manufacturer with the Rando Phantom. Another set of radiopaque 
markers was fixed on the same location but on peripheral side for 
each cast. Each cast was re-positioned and a set of Cone beam 
computed tomography (CBCT) images was taken at different time 
intervals: 0 minute, 30 minutes, 24 hours, 48 hours and 72 hours. Each 
re-position procedure was done repeatedly for five times. The 
displacements between the underlying markers and the peripheral 
markers were then calculated by registering the CBCT imaging 
acquired at different time intervals and the reference planning CBCT. 
Setup errors were then analyzed to investigate the reproducibility of 
thermoplastic casts of both Orfit and CIVCO. 
Results: The displacement differences between 30 min and the 
average of 24hr to 72hr were 0.3mm and 0.6mm for CIVCO and Orfit 
respectively. This indicated that the shrinkage effect of the two 
vender was not significantly different (p>0.05). The average three-
dimensional displacement of CIVCO and Orfit were 1.1mm and 0.9mm 
respectively. It was also not significantly different (P>0.05). 
Conclusions: There was no statistically significantly difference in the 
aspects of shrinkage effect and reproducibility with the thermoplastic 
casts from CIVCO over casts from Orfit. This study has demonstrated 
that both thermoplastic casts were highly effective. 
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Purpose/Objective: This study was designed to compare small bowel 
device (SBD) with belly board (BB) in reduction of irradiated small 
bowel (SB) volume during pelvic radiation therapy (RT) to find out 
whether SBD is replaceable in centers unequipped with BB. 
Materials and Methods: Twenty rectal cancer patients treated with 
pre- or post-operative (PO) radiotherapy from April 2010 to November 
2012 in single institution were enrolled and their RT plans were 
retrospectively reviewed. Both SBD ( N = 11; PO = 3) and BB ( N = 9; 
PO = 2) cohorts received 45 Gy to whole pelvis and boost of 5.4 Gy on 
the tumor bed or anastomosis site. Before adoption of BB, we used 
SBD which was constructed by sculpting a piece of Styrofoam into 
abdominal compressing pillow and then placing it on a vacuum-locked 
cushion suprapubically for immobilization in individual basis and 
maximization of small bowel displacement. SBD group was treated in 
supine position during whole pelvic irradiation regardless of bladder 
filling for patient comfort and then changed position to prone and was 
instructed to keep full bladder while receiving the final 3 fractions 
using SBD, considering the tolerable dose of SB. BB group maintained 
prone position and bladder filling throughout RT using Carbon Fiber 
Bellyboard ( CIVCO ). Only the last 3 cone-down fractions were 
compared to remove any effect by positional difference and bladder 
volume. The SB volumes receiving 1 Gy (V1) to 5.4 Gy (V5.4), total 
(Vtot) and irradiated (Virr) SB volumes below sacral promontory, Virr / 
Vtot in percentage (%irr) and full bladder volume (Vbla) were analyzed 
using the t-test.  
Results: Patients were evenly distributed in both groups considering 
age, sex, body mass index, TNM stage, and operation status.  
 
Mean volume ± SD (cm3) SBD BB P value 
V1 29.16 ± 30.24 29.38 ± 35.88 0.988 
V2 20.19± 24.17 24.85 ± 31.27 0.711 
V3 14.65± 20.39 16.70 ± 24.82 0.842 
V4 10.03 ± 14.30 12.58 ± 19.58 0.740 
V5 7.24± 11.19 10.60 ± 11.28 0.606 
V5.4 4.93 ± 7.79 9.05 ± 16.47 0.470 
Vtot 174.83 ± 146.61 89.5 ± 124.01 0.183 
Virr 92.29 ± 146.34 50.67 ± 66.77 0.442 
Vbla 224.51 ± 179.40 195.00 ± 154.44 0.702 
 
The mean V1, V2, V3, V4, V5 and V5.4 were smaller in patients using 
SBD. The mean %irr (SBD 42.08 ± 43.74 % vs. BB 35.89 ± 42.20 %, P = 
0.753) was lower in BB cohort. The differences in mean Vtot, Virr and 
Vbla between SBD and BB groups were 85.33 cm3, 41.62 cm3 and 29.51 
cm3, respectively.  
Conclusions: No statistically significant difference was found between 
SBD and BB. The number of patients was insufficient to reach the 
desirable statistical power. Another limitation is the restricted dose of 
5.4 Gy only, an inevitable confinement due to the retrospective 
character of the analysis. However, the significance of this study lies 
in the novelty of directly comparing the two non-invasive SB sparing 
devices. A prospective research including sufficient number of 
patients on full course of radiotherapy in prone position with full 
bladder is necessary to augment statistical reliability. Depending on 
the result, SBD may be suggested as an alternative in centers without 
BB. 
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Purpose/Objective: There is growing recognition that prone setup for 
whole breast radiotherapy (RT) can reduce the amount of lung being 
irradiated as compared with supine setup, as confirmed in our 
experience (Fargier-Bochaton et al., abstract 2nd ESTRO Forum 2013). 
There are however challenging issues for implementation of prone 
breast RT in daily practice. One of the issues is the choice of a device 
for prone positioning. In the present study, we aimed to evaluate a 
dedicated couch, the kVue™ Access 360™ Prone Breast Insert, as 
compared with an add-on device used with conventional couches, the 
Bionix Prone Breast Board. 
Materials and Methods: Healthy volunteers were installed and 
remained prone during 10 minutes on either the Access360 couch or 
the Bionix board. A skin mark was drawn on the projection of lateral 
laser cross-lines on the thorax at the end of setup. Timer started 
when skin marking was completed. The displacement between laser 
cross-lines and skin mark was measured at the end of the elapsed 10 
minutes. Pain, discomfort, and instability symptoms were recorded by 
the volunteers using a visual analogue scale, ranging from 0 (absence 
of symptom) to 10 (intolerable symptom). Other recorded data were 
age, sex, weight and height, and computed body mass index (BMI). 
Student's t-test and linear regression were used for the data analyses. 
Results: The Access360 couch was evaluated by 4 males and 4 
females. The Bionix board was evaluated by 3 males and 6 females. 
Characteristics of the volunteers were: mean age 37.3 years (range 25 
- 61), weight 68.2 kg (50 - 112), height 170 cm (160 - 191), BMI 23.5 
(19.5 - 34.2). The overall symptom evaluation, regardless of the type 
of prone device, indicated a mean pain score of 1.3 (range 0-6), 
discomfort 2.8 (1-7), instability 0.9 (0-7). Increased weight was 
significantly associated with pain (P=0.010) and with discomfort (P= 
0.012), but not with instability (P = 0.215). Similarly to weight, 
increased BMI was associated with pain and discomfort but not with 
instability. There was a trend in the association between male gender 
and pain (P = 0.08). Age and height were not significantly associated 
with any of the three symptom scores. In an analysis taking into 
account the type of prone device, there were no significant 
differences between the Access360 couch and the Bionix board 
regarding pain, discomfort, or laser displacement. There was a non 
significant increase of instability associated with the Bionix board as 
compared with the Access360 couch (P = 0.115). In an analysis of 
subgroup effects, the relationship between pain and weight was found 
to be more significant within the Bionix board's group (P=0.001), but 
not within the Access360 couch's group (P=0.643). The relationship 
between discomfort and weight were of comparable order with the 
Bionix board (P=0.070) and with the Access360 couch (P=0.051). The 
relationship between instability and weight approached significance 
when analyzed within the Bionix board's group (P=0.061), but was not 
significant when analyzed within the Access360 couch's group 
(P=0.381). 
Conclusions: The Access360 couch compared favorably with the Bionix 
board. We have started implementing the Access360 in daily practice. 
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Purpose/Objective: In a nationwide survey it became apparent that 
for breast conserving radiotherapy some institutions treat the patients 
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on a flat couch (FC) while others make use of an angulated breast 
board (AB). We, therefore, studied the effect of the patient 
positioning on the dose distribution in the Planning Target Volume 
(PTV) as well as on the (mean) dose to the normal structures. 
Materials and Methods: Ten patients with left-sided breast cancer 
referred for radiotherapy after breast conserving surgery were 
included in our study. All patients underwent a CT-scan on a flat 
couch as well as an angulated breast board, both in supine treatment 
position. To avoid interobserver differences, the Clinical Target 
Volume (CTV), stomach, axilla, plexus brachialis and heart were 
contoured by one observer. The lungs were contoured automatically. 
The PTV trim was defined by enlarging the CTV of the glandular breast 
tissue with 5mm in the AP, LR direction and 6mm in the CC direction, 
and was trimmed 5mm under the skin. We subsequently compared a 
3D-CRT treatment plan in the FC with the AB position. All plans had to 
meet the following criteria: 
- 97% of PTV trim is covered by the 95% isodose (V95%); 
- Maximum Heart Distance: < 1.5 cm; 
- Mean Lung Dose (as based on both lungs): < 7.5 Gy. 
We analyzed the PTVtrim volumes and the mean dose in all delineated 
normal structures in both positions. 
Results: In both positions the mean PTVtrim was 905 cm3 (282 – 1780). 
The PTVtrim was displaced to the cranial part of the patient, see 
figure 1. 
 
  
Figure 1. Patient no. 3. Axial CT-slice at the carina level of the lung: 
Left: flat couch; Right: angulated breast board. 
For PTVtrim, the heart, lungs and stomach no statistically significant 
differences were found. In all patients a significantly higher mean 
dose in the plexus brachialis and axilla was found, see table 1. 
 
Table 1. Flat Angulated p-value 
PTV-V107% (%) 2.4 0 0.08 
PTV-V110% (%) 1.1 0 0.2 
Heart-mean (Gy) 3.2 2.5 0.09 
Mean Lung Dose (Gy) 2.2 1.9 0.07 
Stomach-mean (Gy) 1.2 1.1 0.3 
Plexus Brachialis-mean (Gy) 6.9 2.5 < 0.01 
Axilla-mean (Gy) 30.1 23.4 < 0.01 
 
Conclusions: Between the two positions no differences were noted in 
PTVtrim volume or mean dose in heart, lungs and stomach. 
Furthermore, the dose in the plexus brachialis and axilla was 
increased. Since the introduction of more intensive imaging 
procedures for position verification now obligates the clinician to 
evaluate therapeutic and imaging doses in a more balanced manner. 
The aim is to keep the dose outside the treatment fields 'As Low As 
Reasonably Achievable' (ALARA). Therefore, it seems preferable in 
breast conserving radiotherapy, to use an angulated board to reduce 
the dose in the normal structures. 
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Purpose/Objective: To test whether range shifter optimization, i.e. 
limiting the use of range shifter (RS) only to the energy layers where it 
is strictly needed, allows for high-quality isocentric treatments. 
Materials and Methods: Intensity Modulated Proton Therapy (IMPT) 
plans were performed with a commercial treatment planning system 
(XiO, Elekta, ver. 4.64.02) on four CT datasets of patients with 
different positions and dimensions of target volume: one 
mesothelioma (case 1), one left brain-chondrosarcoma (case 2) and 
two different skull base-chordoma (case 3, case 4).  
The beam model parameters were: sigma dimension range 4.6 (at 100 
MeV) - 1.7 (at 236 MeV), proton pencil beams depth range (without 
range shifter) 7.6 - 32.5 cm.  
For all CT dataset the target volumes were at least in part shallower 
than the minimum depth below which a RS is needed (7.6 cm water 
equivalent depth from patient surface).  
On every dataset, we created four PBS plans setting the fields as 
follows: 
1. RS always in the beam (i.e. for all enerGy (RBE) layers) with 
standard airgap and isocentric fields (RSAG); 
2. RS optimization (i.e. using it only when needed) with standard 
airgap and isocentric fields (RSoptAG); 
3. RS always in the beam with 5 cm airgap, non-isocentric fields 
(RSAGopt); 
4. RS optimization with 5 cm airgap, non-isocentric fields 
(RSoptAGopt). 
In all cases, we used clinically applied prescription dose and OARs 
constraints. 
All plans were performed using two field directions. 
For RSAG and RSoptAG configurations, we used one beam per field 
direction.  
For RSoptAG and RSoptAGopt, we used two beams for field direction, 
one with RS, for delivered the superficial proton pencil beams, and 
the other without, for the others. 
Results: All fields configurations complied with target volume dose 
objectives in all clinical cases.  
Concerning the OARs (Figure1), RSAG configuration is to be avoided 
because results were always the worst and sometimes the OARs 
constraints were not respected. 
RSAGopt is the most commonly used and it provides acceptable 
results, but it significantly disrupts the treatment workflow as an 
operator has to enter the treatment room at every field.  
RSoptAG configuration provided results at least good as RSAGopt and 
sometimes better especially in lesions that required the use of RS only 
for a little portion of the target volume (case 3, case 4). In addition, 
RSoptAG configuration allows to perform isocentric treatment and 
thus to avoid the an operator entering the treatment room between 
fields delivery, thus improving the workflow. 
RSoptAGopt provided always the best results in OARs and target 
coverage but in the practical clinic this treatment settings results to 
be uncomfortable like RSAGopt. 
 
  
Conclusions: Range shifter optimization is a valid alternative in IMPT 
to perform high-quality isocentric treatments for lesions that required 
the use of RS. Simply by optimizing RS, one can improve the workflow 
of a protontherapy center without any impact on the treatment 
quality. 
   
 
 
 
 
